跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ABSTRAL SUBLINGUAL TABLET 200 mcg - HSA Drug Approval Details
Approvals
/
HSA
/
ABSTRAL SUBLINGUAL TABLET 200 mcg
Approved
STANDARD
ABSTRAL SUBLINGUAL TABLET 200 mcg
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
fadf6c556258c773
Company
Unknown
Type
Standard
Approval Details
Approval Id
fadf6c556258c773
Drug Name
ABSTRAL SUBLINGUAL TABLET 200 mcg
Active Ingredients
FENTANYL CITRATE (MICRONIZED) 314.2 μg eqv. FENTANYL
200 µg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
fadf6c556258c773
Type
Standard
Back to HSA Approvals